Changes in plasma prolactin during SSRI treatment: Evidence for a delayed increase in 5-HT neurotransmission

Journal of Psychopharmacology

Volumn 11, Issue 4, 1997, Pages 345-348

  Cowen, P J ^a   Sargent, P A ^a  

^a Littlemore Mental Health Centre   (United Kingdom)

Author keywords

Paroxetine; Prolactin; Serotonin; SSRI

Indexed keywords

PAROXETINE; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTRANSMISSION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0030781791     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119701100410     Document Type: Article

References (32)

1. Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archs Gen Psychiat 51: 248-251
2. Asberg M, Erikkson B, Matensson B, Traskman-Bendz L, Wagner A (1986) Therapeutic effects of serotonin uptake inhibitors in depression. J Clin Psychiat 47: 23-35
3. Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmac Sci 15: 220-226
4. Carboni E, Di Chiara G (1989) Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 32: 637-645
5. Chaput Y, Blier P, de Montigny C (1986) In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 6: 2796-2801
6. Cowen P J (1993) Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin Neuropharmac 16 (Suppl. 3): S6-S18
7. Deakin J F W, Graeff F G (1991) 5-HT and mechanisms of defence. J Psychopharmac 5: 305-315
8. Den Boer J A, Westenberg H G M (1988) Effect of a serotonin and noradrenaline reuptake inhibitor in panic disorder, a double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmac 3: 59-74
9. Fuller R W (1994) Mini-review: uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 55: 163-167
10. Gardier A M, Lepoul E, Trouvin J H, Chanut E, Dessalles M C, Jacquot C (1993) Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment: relationship with brain concentrations of fluoxetine and of norfluoxetine. Life Sci 54: 51-56
11. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmac 115: 1064-1070
12. Golden R N, Hsiao J, Lane E, Hicks R, Rogers S, Potter W Z (1989) The effects of intravenous clomipramine on neurohormones in normal subjects. J Clin Endocrin Metab 68: 632-637
13. Goodall E M, Cowen P J, Franklin M, Silverstone T (1993) Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology 112: 461-466
14. Laakmann G, Schumacher G, Benkert O, von Weerder K (1977) Stimulation of growth hormone secretion by desipramine and clorimipramine in man. J Clin Endocrin Metab 44: 1010-1013
15. Laakmann G, Gugath M, Kuss H J, Zygan K (1984) Comparison of growth hormone and prolactin stimulation induced by chlorimipramine and desipramine in man in connection with chlorimipramine metabolism. Psychopharmacology 82: 62-67
16. Lee M A, Nash J F, Barnes M, Meltzer H Y (1991) Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans. Psychopharmacology 103: 258-264
17. 1A receptor responsivity in obsessive compulsive disorder. Psychopharmacology 105: 415-420
18. Meltzer H Y, Maes M (1994) Effects of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man. Psychopharmacology 114: 635-643
19. Meltzer H Y, Nash J F (1988) Serotonin and mood: neuroendocrine aspects. In Ganten D, Pfaff D (eds), Current topics in neuroendincrinology, Vol. 8. Springer, Berlin
20. O'Keane V, O'Hanlon M, Webb M, Dinan T (1991) D-fenfluramine/ prolactin response throughout the menstrual cycle: evidence for an oestrogen induced alteration. Clin Endocrin 34: 289-292
21. Park S B G, Cowen P J (1995) Effect of pindolol on the prolactin response to d-fenfluramine. Psychopharmacology 118: 471-474
22. Price L H, Charney D S, Delgado P L, Anderson G M, Heninger G R (1989) Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan: serotonergic function and the mechanism of antidepressant action. Archs Gen Psychiat 46: 625-631
23. Rigdon G C, Wang C M (1991) Serotonin uptake blockers inhibit the firing of presumed serotonergic dorsal raphé neurones in vitro. Drug Dev Res 22: 135-140
24. Rutter J J, Auerbach S B (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J Pharmac Exp Ther 265: 1319-1324
25. Sargent P A, Hockney R, Dowling B, Campling G, Cowen P J (1996) Adaptive changes in 5-HT neurotransmission during paroxetine treatment. J Psychopharmac 10 (Suppl.): A34, 134
26. 1A receptor sensitivity. Psychopharmacology 132: 296-302
27. Seifritz E, Baumann P, Muller M J, Annen O, Amey M, Hemmeter U, Hatzinger M, Chardon F, Holsboer-Trachsler E (1996) Neuroendocrine effects of a 20 mg citalopram infusion in healthy males. Neuropsychopharmacology 14: 253-263
28. Tanda G, Carboni E, Frau R, Di Chiara G (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 115: 285-288
29. Tuomisto J, Mannisto P (1985) Neurotransmitter regulation of anterior pituitary hormones. Pharmac Rev 37: 249-332
30. Van de Kar L D (1991) The neuroendocrine pharmacology of serotonergic (5-HT) neurones. Ann Rev Pharmac Toxic 31: 289-320
31. Wing Y-K, Clifford E M, Sheehan B D, Campling G M, Hockney R A, Cowen P J (1996) Paroxetine treatment and the prolactin response to sumatriptan. Psychopharmacology 124: 377-379
32. Zohar J, Insel T R, Zohar-Kadouch R C, Hill J L, Murphy D L (1988) Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment. Archs Gen Psychiat 45: 167-172